Hologic Inc. (NASDAQ: HOLX) stock closed at 76.66 per share at the end of the most recent trading day (a 0.88% change compared to the prior day closing price) with a volume of 1.76M shares and market capitalization of 19.75B. Is a component of S&P 500, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 5814 people. Hologic Inc. CEO is Stephen P. Macmillan.

The one-year performance of Hologic Inc. stock is 84.39%, while year-to-date (YTD) performance is 5.26%. HOLX stock has a five-year performance of 111.94%. Its 52-week range is between 41.03 and 85, which gives HOLX stock a 52-week price range ratio of 81.03%

Hologic Inc. currently has a PE ratio of 14.00, a price-to-book (PB) ratio of 5.80, a price-to-sale (PS) ratio of 5.07, a price to cashflow ratio of 13.50, a PEG ratio of 2.32, a ROA of 19.19%, a ROC of 25.81% and a ROE of 48.39%. The company’s profit margin is 33.95%, its EBITDA margin is 49.00%, and its revenue ttm is $3.78 Billion , which makes it $14.67 revenue per share.

Of the last four earnings reports from Hologic Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.61 for the next earnings report. Hologic Inc.’s next earnings report date is 28th Apr 2021.

The consensus rating of Wall Street analysts for Hologic Inc. is Moderate Buy (2), with a target price of $86, which is +12.18% compared to the current price. The earnings rating for Hologic Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Hologic Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Hologic Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 13.54, ATR14 : 2.79, CCI20 : 141.51, Chaikin Money Flow : 0.11, MACD : -0.71, Money Flow Index : 77.33, ROC : 3.78, RSI : 49.72, STOCH (14,3) : 89.46, STOCH RSI : 1.00, UO : 56.44, Williams %R : -10.54), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Hologic Inc. in the last 12-months were: Allison P. Bebo (Sold 6 100 shares of value $512 778 ), Benjamin J. Cohn (Option Excercise at a value of $709 146), Benjamin J. Cohn (Sold 26 339 shares of value $1 992 182 ), Christiana Stamoulis (Option Excercise at a value of $249 113), Christiana Stamoulis (Sold 11 146 shares of value $824 804 ), John M. Griffin (Option Excercise at a value of $1 073 940), John M. Griffin (Sold 27 806 shares of value $1 872 989 ), Karleen M. Oberton (Option Excercise at a value of $536 283), Karleen M. Oberton (Sold 15 000 shares of value $937 500 ), Kevin R. Thornal (Option Excercise at a value of $1 013 885), Kevin R. Thornal (Sold 30 757 shares of value $1 963 639 ), Peter J. Valenti (Option Excercise at a value of $550 043), Peter J. Valenti (Sold 20 986 shares of value $1 111 135 ), Sally W. Crawford (Sold 63 900 shares of value $3 322 160 ), Scott T. Garrett (Option Excercise at a value of $1 233 732), Stephen P. Macmillan (Option Excercise at a value of $4 814 551), Stephen P. Macmillan (Sold 190 996 shares of value $9 735 257 )